RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
Use this RAPT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RAPT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RAPT SEC filings page. Lician reads the product cache first so this HTML stays unique to RAPT Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full RAPT income, balance, and cash tables.